Skip to search formSkip to main contentSkip to account menu

AIDS Vaccines

Known as: vaccine AIDS, AIDS Vaccines [Chemical/Ingredient], aid vaccines 
Vaccines or candidate vaccines containing inactivated HIV or some of its component antigens and designed to prevent or treat AIDS. Some vaccines… 
National Institutes of Health

Related topics

Related topics

26 relations

Narrower (17)

AIDSVAXAIDSVAX B-EDNA-rAd5 vaccineDermaVir
HIV VaccineIn BloodProcess of secretionagonists

Broader (1)

Viral Vaccines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
Immunology and the elusive AIDS vaccine
Developing a human immunodeficiency virus (HIV) vaccine is critical to end the global acquired immunodeficiency syndrome (AIDS… 
Review
2007
Review
2007
HIV/AIDS Vaccines: 2007
Development of an HIV/AIDS vaccine has been slow because classical approaches to vaccine development have not yielded a vaccine… 
Highly Cited
2004
Highly Cited
2004
Safety profile of recombinant canarypox HIV vaccines.
Highly Cited
2002
Highly Cited
2002
Critical Role for Env as well as Gag-Pol in Control of a Simian-Human Immunodeficiency Virus 89.6P Challenge by a DNA Prime/Recombinant Modified Vaccinia Virus Ankara Vaccine
ABSTRACT Cellular immune responses against epitopes in conserved Gag and Pol sequences of human immunodeficiency virus type 1… 
Highly Cited
2001
Highly Cited
2001
Knowledge About Vaccine Trials and Willingness to Participate in an HIV/AIDS Vaccine Study in the Ugandan Military
Summary: In preparation for HIV vaccine trials, knowledge about vaccines, willingness to participate in a vaccine study, and… 
Highly Cited
1995
Highly Cited
1995
Lack of induction of antibodies specific for conserved, discontinuous epitopes of HIV-1 envelope glycoprotein by candidate AIDS vaccines.
We examined the humoral immune response in both HIV-1 infected and uninfected volunteers immunized with candidate HIV-1… 
Highly Cited
1994
Highly Cited
1994
Studies of high doses of a human immunodeficiency virus type 1 recombinant glycoprotein 160 candidate vaccine in HIV type 1-seronegative humans
We examined the safety and immunogenicity of a baculovirus-derived recombinant HIV-1 envelope glycoprotein vaccine candidate… 
Review
1993
Review
1993
Jitters jeopardize AIDS vaccine trials.
AIDS vaccine developers have been planning large-scale tests of experimental vaccines in people at high risk of becoming infected… 
Highly Cited
1992
Highly Cited
1992
Macromolecular assemblage in the design of a synthetic AIDS vaccine.
We describe a peptide vaccine model based on the mimicry of surface coat protein of a pathogen. This model used a macromolecular… 
Review
1988
Review
1988
Development and testing of AIDS vaccines.
Recent advances in delineating the molecular biology of human immunodeficiency virus type 1 (HIV-1) have led to innovative… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)